Anti-Serpin-A3 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-A3, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey
UniProt
P01011
Size
100ug
Cat. #
RP2SerpinA3

In stock

SKU
RP-SerpinA3

Options

As low as: $130.00

Target Overview

Serpin-A3 (SERPINA3, UniProt P01011), also known as alpha-1-antichymotrypsin (ACT), is a secreted serine protease inhibitor belonging to the serpin superfamily. The mature protein comprises 423 amino acids and functions as an acute-phase reactant synthesized primarily in the liver, though expression has been documented in other tissues including brain, lung, and sites of inflammation. While its precise physiological role remains incompletely defined, Serpin-A3 inhibits neutrophil cathepsin G and mast cell chymase, both of which participate in angiotensin processing by converting angiotensin-1 to the vasoactive angiotensin-2. The protein circulates at basal concentrations of 0.3–0.6 mg/mL in human plasma and increases several-fold during acute-phase responses. Researchers study Serpin-A3 in contexts ranging from inflammation and sepsis to neurodegenerative disease and cancer, where altered expression or secretion may reflect underlying pathology or contribute to disease mechanisms.

Background

Serpin-A3 belongs to the clade A serine protease inhibitor family and employs the characteristic serpin mechanism: suicide substrate inhibition via formation of a covalent enzyme-inhibitor complex. Its primary targets include cathepsin G and chymase, endopeptidases involved in extracellular matrix remodeling, immune cell activation, and vasoactive peptide processing. Although initially characterized as an acute-phase protein upregulated during infection and tissue injury, recent work has expanded the functional repertoire of Serpin-A3 to include roles in cellular stress responses and tissue homeostasis. Emerging evidence links Serpin-A3 to diverse pathological states. Xue et al. (2026) reported altered plasma SERPINA3 levels in adolescent major depressive disorder, suggesting potential involvement in neuroinflammatory or stress-axis dysregulation. In oncology, Kim et al. (2026) identified SERPINA3 as a secreted biomarker associated with poor prognosis and T-cell dysfunction in non-small cell lung cancer, implicating the protein in immune evasion or tumor microenvironment remodeling. Chiang et al. (2026) detected Serpin-A3 in extracellular vesicle proteomes during Staphylococcus aureus-induced sepsis, consistent with its participation in coordinated acute-phase and complement responses. Additional studies have explored SERPINA3 in the context of Alzheimer disease, postoperative delirium, and endoplasmic reticulum stress in neuroblastoma, underscoring the breadth of research interest. Three rabbit polyclonal antibodies raised against the amino-terminal region of mature Serpin-A3 are available from Triple Point Biologics, validated for Western blot, with predicted cross-reactivity in non-human primates.

References

  1. Chiang DM et al (2026) Extracellular vesicle proteomics in staphylococcus aureus-treated blood and sepsis reveals coordinated complement, acute phase, neutrophil, and exocytosis responses. Sci Rep. PubMed · DOI
  2. Fang Y et al (2026) Common biomarkers of Alzheimer disease and postoperative delirium. Medicine (Baltimore). PubMed · DOI
  3. Lu W et al (2026) Identification and analysis of endoplasmic reticulum stress-related genes in neuroblastoma and construction of a prognostic gene signature. Transl Cancer Res. PubMed · DOI
  4. Xue Y et al (2026) Plasma SERPINA3 and its clinical correlates in adolescent major depressive disorder: an exploratory case-control study. BMC Psychiatry. PubMed · DOI
  5. Kim J et al (2026) SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-cell Dysfunction in Non-Small Cell Lung Cancer. Tuberc Respir Dis (Seoul). PubMed · DOI

Additional Specifications

Gene Symbol SERPINA3
UniProt ID P01011
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey
Pack Size 100ug
Immunogen (Amino end mature Serpin-A3)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 24-74.
Immunogen (Helix 4 to Helix 5)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 200-270.
Immunogen (Helix 7 to Helix 8)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 310-380.
Alternate Names Alpha-1-antichymotrypsin, ACT, Serpin A3, SERPINA3, Cell growth-inhibiting gene 24/25 protein, Alpha-1-antichymotrypsin His-Pro-less

Frequently Asked Questions

What molecular weight should I expect for Serpin-A3 on a Western blot?

Serpin-A3 (alpha-1-antichymotrypsin) typically migrates at approximately 55–68 kDa on reducing SDS-PAGE, though the mature secreted protein comprises 423 amino acids with a calculated mass near 47 kDa. The discrepancy reflects extensive N-glycosylation at multiple sites. You may observe a broad or smeared band due to glycosylation heterogeneity, particularly in plasma or serum samples. Liver lysates and conditioned media from hepatocyte cultures are reliable positive controls. Start with the recommended 1:1000 dilution in 5-percent non-fat milk or BSA; overnight incubation at 4°C often improves sensitivity for this secreted target.

Is this Serpin-A3 antibody validated for human samples only or does it detect mouse and rat?

This polyclonal antibody is validated for human Serpin-A3 detection by Western blot and immunohistochemistry. Cross-reactivity with non-human primate samples is predicted based on sequence homology but remains experimentally unconfirmed in our hands. Mouse and rat orthologues share lower sequence identity in key epitope regions, so cross-reactivity is not expected. If you work with rodent models, consider species-specific reagents or perform a pilot blot with mouse liver lysate alongside human control to empirically test cross-reactivity before committing to a full experiment. We cannot guarantee performance outside validated human applications.

What is the best positive control tissue or cell line for Serpin-A3 Western blots?

Human liver lysate serves as the strongest positive control because hepatocytes are the primary site of Serpin-A3 synthesis under basal and acute-phase conditions. Human plasma or serum diluted in sample buffer also works well, given circulating concentrations of 0.3–0.6 mg/mL at baseline. For cell lines, HepG2 hepatoma lysates typically express detectable Serpin-A3. If studying inflammation or extrahepatic expression, lysates from stimulated monocytes or brain tissue may show inducible signal, though at lower abundance. Always include a no-primary-antibody or isotype control lane to confirm specificity, especially when working with complex tissue extracts.

Can this antibody distinguish between Serpin-A3 isoforms or splice variants?

Human SERPINA3 does not exhibit well-characterized splice variants that produce distinct protein isoforms in most tissues. The primary transcript encodes a single mature 423-amino-acid secreted protein. However, extensive post-translational glycosylation generates microheterogeneity visible as band broadening on Western blots. This polyclonal antibody was raised against a large fragment spanning residues encompassing much of the mature protein, so it will not discriminate between glycoforms. If your experimental question centers on glycosylation state, consider enzymatic deglycosylation with PNGase F prior to SDS-PAGE to collapse the signal into a single sharper band near 47 kDa.

What dilution should I start with for immunohistochemistry on formalin-fixed paraffin-embedded tissue?

We recommend starting at 1:200 to 1:500 for IHC on formalin-fixed paraffin-embedded human tissue sections. Antigen retrieval is typically required; citrate buffer (pH 6.0) heat-mediated retrieval for 20 minutes works well for many serpin targets. Serpin-A3 expression localizes predominantly to hepatocytes in liver and to reactive astrocytes or sites of inflammation in brain. Include a known positive tissue (normal human liver) and a no-primary-antibody control on adjacent sections. Because Serpin-A3 is a secreted protein, expect cytoplasmic and extracellular staining. Optimize blocking and detection reagents to minimize background in connective tissue.

How should I prepare cell lysates to preserve Serpin-A3 for Western blot detection?

Serpin-A3 is a secreted protein, so you may recover more target from conditioned culture medium than from intracellular lysates, particularly in hepatocyte or HepG2 cultures. For lysates, use RIPA or similar detergent buffer supplemented with protease inhibitors; serpin structure is relatively stable, but include a cocktail to prevent artifactual cleavage. Clarify lysates by centrifugation at 16,000 × g for ten minutes at 4°C. Quantify protein by BCA or Bradford and load 20–40 µg total protein per lane. Because Serpin-A3 is glycosylated, avoid prolonged boiling; heat samples at 95°C for five minutes in reducing sample buffer to preserve band sharpness.

Does Serpin-A3 expression increase under inflammatory or acute-phase conditions, and will this antibody detect it?

Yes, Serpin-A3 is a canonical acute-phase reactant; hepatic synthesis increases several-fold in response to interleukin-6 and other inflammatory cytokines. Plasma concentrations can rise from baseline 0.3–0.6 mg/mL to well over 1 mg/mL during infection, trauma, or chronic inflammation. This polyclonal antibody detects both basal and induced Serpin-A3 with equal affinity, so it is well suited for studies comparing resting versus stimulated conditions. When quantifying induction by Western blot, ensure your linear range is not exceeded; you may need to load less total protein or dilute samples from acute-phase plasma to avoid saturating the signal.

How should I store this antibody, and how long will it remain stable after opening?

Store the antibody at –20°C as supplied. After opening, we recommend aliquoting into single-use volumes to avoid repeated freeze-thaw cycles, which can reduce titre over time. Polyclonal antibodies typically retain activity for at least 12 months when stored as frozen aliquots at –20°C. For frequent use, a working aliquot may be kept at 4°C for up to one month in the presence of 0.02-percent sodium azide or similar preservative; verify that azide does not interfere with HRP-based detection in your system. Do not store diluted antibody in blocking buffer for more than a few days. Always centrifuge thawed aliquots briefly before use to pellet any aggregates.

Validation imagery coming soon

Western blot validation figures for RP-SerpinA3 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • Alpha-1-antichymotrypsin
  • ACT
  • Serpin A3
  • SERPINA3
  • Cell growth-inhibiting gene 24/25 protein
  • Alpha-1-antichymotrypsin His-Pro-less
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →